CN115400165A - Eucalyptus leaf extract, preparation method and application thereof in preparation of weight-losing and lipid-lowering products - Google Patents
Eucalyptus leaf extract, preparation method and application thereof in preparation of weight-losing and lipid-lowering products Download PDFInfo
- Publication number
- CN115400165A CN115400165A CN202211003304.4A CN202211003304A CN115400165A CN 115400165 A CN115400165 A CN 115400165A CN 202211003304 A CN202211003304 A CN 202211003304A CN 115400165 A CN115400165 A CN 115400165A
- Authority
- CN
- China
- Prior art keywords
- eucalyptus
- preparation
- eucalyptus leaf
- leaf extract
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种桉叶提取物、制备方法及其在制备减肥降脂产品中的应用,属于植物提取技术领域。本发明通过采用多溶剂低温连续相变萃取、柱层析分离等工艺,解决了现有技术中桉叶有效成分的提取率较低、提取产物活性较差等问题。本发明的桉叶提取物的制备方法可以实现较高除杂率,操作步骤简单且得率高。通过本发明制备方法得到的桉叶提取物多酚含量更高、总收率更高,并且具有很好的减肥降脂作用,能够有效控制机体重量,调节血脂水平,有效预防及改善肥胖。此外,桉叶资源丰富价格低廉,制备方法简单、成本低廉,符合工业化生产要求,有开发作为药品或者保健品的实际意义和应用价值,因此本发明也提高了桉叶资源的利用率。
The invention provides a eucalyptus leaf extract, a preparation method and its application in the preparation of weight-loss and lipid-lowering products, belonging to the technical field of plant extraction. The invention solves the problems of low extraction rate of effective components of eucalyptus leaves, poor activity of extraction products and the like in the prior art by adopting processes such as multi-solvent low-temperature continuous phase change extraction and column chromatography separation. The preparation method of the eucalyptus leaf extract of the present invention can realize high impurity removal rate, simple operation steps and high yield. The eucalyptus leaf extract obtained by the preparation method of the invention has higher polyphenol content and higher total yield, and has a good weight loss and fat-lowering effect, can effectively control body weight, regulate blood lipid levels, and effectively prevent and improve obesity. In addition, eucalyptus resources are abundant and cheap, and the preparation method is simple and low in cost, which meets the requirements of industrial production and has practical significance and application value for development as medicine or health care products. Therefore, the present invention also improves the utilization rate of eucalyptus resources.
Description
技术领域technical field
本发明涉及植物提取技术领域,尤其涉及一种桉叶提取物、制备方法及其在制备减肥降脂产品中的应用。The invention relates to the technical field of plant extraction, in particular to a eucalyptus leaf extract, a preparation method and its application in the preparation of weight-loss and lipid-lowering products.
背景技术Background technique
近年来,随着生活水平的不断提高,不健康的作息及饮食方式导致的营养性肥胖病发病率日渐增高。据报道,营养性肥胖会增加高血压、Ⅱ型糖尿病、冠心病及癌症的发病风险,使机体健康受到极大影响。因此,如何有效预防和治疗肥胖症已经成为世界范围内公共安全健康问题之一。减肥药物虽然能够有效控制体重,但长期服用可能会对机体造成不良影响。因此,开发安全、无毒副作用的减肥降脂功能性天然产物的市场需求逐渐释放,未来行业发展前景良好。In recent years, with the continuous improvement of living standards, the incidence of nutritional obesity caused by unhealthy work and rest and eating patterns is increasing day by day. According to reports, nutritional obesity will increase the risk of hypertension,
我国桉树资源丰富,具有面积大、地域广、品种多等特点。桉叶作为桉树的副产物一直作为民间传统中草药,常用作清热解毒治感冒等用途。已有研究表明桉叶提取物含有大量多酚类物质,在体内和体外均显示出较强的抗氧化活性,其抗衰老、抗肿瘤、抗糖尿病、抗炎等一系列功效也被报道,但化学法、酶法等现有方法对桉叶有效成分的提取率较低、提取产物活性较差,限制了其在产业中的应用。目前,尚未见到采用桉叶提取物预防及治疗肥胖症的相关报道。Our country is rich in eucalyptus resources, which have the characteristics of large area, wide area and many varieties. As a by-product of eucalyptus, eucalyptus has been used as a traditional Chinese herbal medicine, and is often used for clearing away heat, detoxifying and treating colds. Existing studies have shown that eucalyptus leaf extract contains a large amount of polyphenols, which show strong antioxidant activity in vivo and in vitro, and a series of effects such as anti-aging, anti-tumor, anti-diabetes, and anti-inflammation have also been reported, but The existing methods such as chemical method and enzymatic method have low extraction rate of active components of eucalyptus leaves, and the activity of the extracted product is poor, which limits its application in industry. At present, there are no relevant reports on the prevention and treatment of obesity using eucalyptus leaf extract.
发明内容Contents of the invention
本发明的目的在于提供一种桉叶提取物、制备方法及其在制备减肥降脂产品中的应用,解决了现有技术中桉叶有效成分的提取率较低、提取产物活性较差等问题。The object of the present invention is to provide a eucalyptus leaf extract, a preparation method and its application in the preparation of weight loss and lipid-lowering products, which solves the problems of low extraction rate of active ingredients of eucalyptus leaf and poor activity of the extracted product in the prior art. .
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned purpose of the invention, the present invention provides the following technical solutions:
本发明提供了一种桉叶提取物的制备方法,包含如下步骤:The present invention provides a kind of preparation method of eucalyptus leaf extract, comprises the following steps:
将桉叶进行粉碎,得到桉叶粉;Pulverizing eucalyptus leaves to obtain eucalyptus leaf powder;
将桉叶粉进行连续相变萃取,得到提取液;The eucalyptus leaf powder is subjected to continuous phase change extraction to obtain an extract;
将提取液依次进行浓缩、喷雾干燥,得到桉叶粗提物;Concentrating and spray-drying the extract in sequence to obtain the crude extract of eucalyptus leaves;
将桉叶粗提物进行纯化,得到桉叶提取物;purifying the crude extract of eucalyptus to obtain an extract of eucalyptus;
所述连续相变萃取采用的萃取剂依次为丁烷、乙醇水溶液和水。The extractant used in the continuous phase change extraction is butane, ethanol aqueous solution and water in sequence.
优选的,所述桉叶粉的粒径在550μm以下。Preferably, the particle size of the eucalyptus leaf powder is below 550 μm.
优选的,所述连续相变萃取的萃取压力为0.5~1.5MPa,萃取温度为55~65℃,解析温度为65~75℃,每种萃取剂的萃取时间为80~120min。Preferably, the extraction pressure of the continuous phase change extraction is 0.5-1.5 MPa, the extraction temperature is 55-65 °C, the analysis temperature is 65-75 °C, and the extraction time of each extractant is 80-120 min.
优选的,所述纯化采用硅胶柱分离,所述硅胶柱分离采用的硅胶柱的目数为100~300目。Preferably, the purification adopts silica gel column separation, and the mesh number of the silica gel column used for the silica gel column separation is 100-300 mesh.
优选的,所述硅胶柱分离过程中采用梯度洗脱,所述梯度洗脱的洗脱流速为30~50ml/min。Preferably, gradient elution is adopted in the separation process of the silica gel column, and the elution flow rate of the gradient elution is 30-50 ml/min.
优选的,所述硅胶柱分离采用的洗脱液包括组分A和组分B;Preferably, the eluent used for the silica gel column separation includes component A and component B;
所述组分A为乙醇,组分B为乙酸乙酯或石油醚。The component A is ethanol, and the component B is ethyl acetate or petroleum ether.
优选的,所述梯度洗脱的过程中,组分A和组分B的体积比依次为0:100、10:90、20:80、30:70、40:60、50:50、60:40、70:30、80:20、90:10、100:0,梯度洗脱结束后,收集组分A和组分B的体积比为60:40、70:30、80:20的洗脱产物;Preferably, in the process of gradient elution, the volume ratio of component A and component B is 0:100, 10:90, 20:80, 30:70, 40:60, 50:50, 60: 40, 70:30, 80:20, 90:10, 100:0, after the end of the gradient elution, collect the elution with the volume ratio of component A and component B at 60:40, 70:30, 80:20 product;
每个体积比的洗脱液洗脱2~4个柱体积。Each volume ratio of the eluent elutes 2 to 4 column volumes.
优选的,将所述洗脱产物进行浓缩、喷雾干燥,得到桉叶提取物。Preferably, the eluted product is concentrated and spray-dried to obtain eucalyptus leaf extract.
本发明还提供了由上述制备方法制备得到的桉叶提取物,包括月见草素B10~20%,特里马素Ⅰ1~2%,槲皮素-3-O-葡萄糖苷酸1~1.5%,没食子酸0.8~1.2%,特里马素Ⅱ0.2~0.5%,1,2,3,4,6五没食子酰葡萄糖3~6%,所述桉叶提取物中总酚含量为50~60%。The present invention also provides the eucalyptus leaf extract prepared by the above preparation method, including 10-20% of evening primrose B, 1-2% of trimarin I, 1-1.5% of quercetin-3-O-glucuronide %, 0.8-1.2% gallic acid, 0.2-0.5% tremasin Ⅱ, 3-6% 1,2,3,4,6 pentagalloyl glucose, the total phenol content in the eucalyptus leaf extract is 50% ~60%.
本发明还提供了上述桉叶提取物在制备减肥降脂产品中的应用。The present invention also provides the application of the above eucalyptus leaf extract in the preparation of weight-loss and lipid-lowering products.
本发明的技术效果和优点:Technical effect and advantage of the present invention:
本发明的桉叶提取物的制备方法可以实现较高除杂率,操作步骤简单且得率高。通过本发明制备方法得到的桉叶提取物多酚含量更高、总收率更高,适宜在实际工业中应用。经检测得知,通过本发明得到的桉叶提取物具有很好的减肥降脂作用,能够有效控制机体重量,调节血脂水平,有效预防及改善肥胖。此外,桉叶资源丰富价格低廉,制备方法简单、成本低廉,符合工业化生产要求,有开发作为药品或者保健品的实际意义和应用价值,也在一定程度上提高了桉叶资源的利用率。The preparation method of the eucalyptus leaf extract of the present invention can realize high impurity removal rate, simple operation steps and high yield. The eucalyptus leaf extract obtained by the preparation method of the invention has higher polyphenol content and higher total yield, and is suitable for practical industrial application. It is found through testing that the eucalyptus leaf extract obtained by the present invention has a good weight-loss and lipid-lowering effect, can effectively control body weight, regulate blood lipid levels, and effectively prevent and improve obesity. In addition, eucalyptus leaf resources are abundant and cheap, and the preparation method is simple and low-cost, which meets the requirements of industrial production. It has practical significance and application value for development as medicine or health care products, and also improves the utilization rate of eucalyptus leaf resources to a certain extent.
附图说明Description of drawings
图1为液相色谱分析结果;Fig. 1 is liquid chromatography analysis result;
图2为小鼠血清中总甘油三酯含量测定结果;Fig. 2 is the measurement result of total triglyceride content in mouse serum;
图3为小鼠血清中总胆固醇含量测定结果;Fig. 3 is the measurement result of total cholesterol content in mouse serum;
图4为小鼠血清中低密度脂蛋白含量测定结果;Fig. 4 is the determination result of low-density lipoprotein content in mouse serum;
图5为小鼠血清中高密度脂蛋白含量测定结果。Fig. 5 is the measurement result of high-density lipoprotein content in mouse serum.
具体实施方式Detailed ways
本发明提供了本发明提供了一种桉叶提取物的制备方法,包含如下步骤:The present invention provides the present invention provides a kind of preparation method of eucalyptus leaf extract, comprises the following steps:
将桉叶进行粉碎,得到桉叶粉;Pulverizing eucalyptus leaves to obtain eucalyptus leaf powder;
将桉叶粉进行连续相变萃取,得到提取液;The eucalyptus leaf powder is subjected to continuous phase change extraction to obtain an extract;
将提取液依次进行浓缩、喷雾干燥,得到桉叶粗提物;Concentrating and spray-drying the extract in sequence to obtain the crude extract of eucalyptus leaves;
将桉叶粗提物进行纯化,得到桉叶提取物;purifying the crude extract of eucalyptus to obtain an extract of eucalyptus;
所述连续相变萃取采用的萃取剂为丁烷、乙醇水溶液和水。The extractant used in the continuous phase change extraction is butane, ethanol aqueous solution and water.
在本发明中,所述桉叶优选在阴凉干燥后进行粉碎得到桉叶粉,所述桉叶粉的粒径优选在550μm以下,进一步优选在350μm以下;将桉叶粉进行连续相变萃取,所述连续相变萃取优选采用连续相变萃取釜进行,所述连续相变萃取的萃取压力优选为0.5~1.5MPa,进一步优选为0.8~1.2MPa,萃取温度优选为55~65℃,进一步优选为58~62℃,解析温度优选为65~75℃,进一步优选为68~72℃,每次的萃取时间优选为80~120min,进一步优选为90~110min;所述连续相变萃取采用的萃取剂为丁烷、乙醇水溶液和水,本发明对萃取的顺序没有要求,所述乙醇水溶液的体积浓度优选为60~80%。In the present invention, the eucalyptus leaves are preferably pulverized after drying in the shade to obtain eucalyptus leaf powder, the particle size of the eucalyptus leaf powder is preferably below 550 μm, more preferably below 350 μm; the eucalyptus leaf powder is subjected to continuous phase change extraction, The continuous phase-change extraction is preferably carried out using a continuous phase-change extraction tank, the extraction pressure of the continuous phase-change extraction is preferably 0.5-1.5 MPa, more preferably 0.8-1.2 MPa, and the extraction temperature is preferably 55-65°C, and more preferably is 58~62°C, the analysis temperature is preferably 65~75°C, more preferably 68~72°C, and the extraction time is preferably 80~120min, more preferably 90~110min; the extraction used in the continuous phase change extraction The solvents are butane, ethanol aqueous solution and water, and the present invention has no requirement on the order of extraction, and the volume concentration of the ethanol aqueous solution is preferably 60-80%.
在本发明中,所述浓缩优选采用真空减压浓缩,所述真空减压浓缩的温度优选为55~70℃、真空度优选为300~500Pa,所述喷雾干燥的进风温度优选为200~250℃,进料速度优选为80~120rpm,雾化器频率优选为40~50Hz。In the present invention, the concentration is preferably vacuum concentration, the temperature of the vacuum concentration is preferably 55-70°C, the vacuum degree is preferably 300-500Pa, and the air inlet temperature of the spray drying is preferably 200-70°C. 250°C, the feed rate is preferably 80-120 rpm, and the atomizer frequency is preferably 40-50 Hz.
在本发明中,所述纯化优选采用硅胶柱分离,所述硅胶柱分离采用的硅胶柱的目数优选为100~300目,进一步优选为150~250目;所述硅胶柱分离过程中优选采用梯度洗脱,所述梯度洗脱的洗脱流速优选为30~50ml/min,进一步优选为35~45ml/min;本发明所述硅胶柱分离采用的洗脱液优选包括组分A和组分B,所述组分A优选为乙醇,组分B优选为乙酸乙酯或石油醚;所述梯度洗脱的过程中,组分A和组分B的体积比优选依次为0:100、10:90、20:80、30:70、40:60、50:50、60:40、70:30、80:20、90:10、100:0,梯度洗脱结束后,收集组分A和组分B的体积比为60:40、70:30、80:20的洗脱产物;本发明中,每个体积比的洗脱液优选洗脱2~4个柱体积,梯度洗脱结束后,优选将所述洗脱产物进行浓缩、喷雾干燥,得到桉叶提取物,所述浓缩优选采用真空浓缩,所述真空浓缩的温度优选为65~85℃、真空度优选为400~600Pa,所述喷雾干燥的进风温度优选为250~300℃,进料速度优选为100~150rpm,雾化器频率优选为50~60Hz。In the present invention, the purification preferably adopts silica gel column separation, and the mesh number of the silica gel column used for the silica gel column separation is preferably 100-300 mesh, more preferably 150-250 mesh; Gradient elution, the elution flow rate of the gradient elution is preferably 30-50ml/min, more preferably 35-45ml/min; the eluent used for the silica gel column separation of the present invention preferably includes component A and component B, the component A is preferably ethanol, and the component B is preferably ethyl acetate or petroleum ether; in the process of gradient elution, the volume ratio of component A and component B is preferably sequentially 0:100, 10 :90, 20:80, 30:70, 40:60, 50:50, 60:40, 70:30, 80:20, 90:10, 100:0, after the gradient elution ends, collect fraction A and The volume ratio of component B is the elution product of 60:40, 70:30, 80:20; in the present invention, the eluent of each volume ratio is preferably eluted in 2 to 4 column volumes, after the gradient elution ends , preferably the eluted product is concentrated and spray-dried to obtain eucalyptus leaf extract, the concentration is preferably vacuum concentration, the temperature of the vacuum concentration is preferably 65-85°C, and the degree of vacuum is preferably 400-600Pa. The air inlet temperature of the spray drying is preferably 250-300° C., the feeding speed is preferably 100-150 rpm, and the atomizer frequency is preferably 50-60 Hz.
本发明还提供了由上述制备方法制备得到的桉叶提取物。The present invention also provides the eucalyptus leaf extract prepared by the above preparation method.
本发明还提供了上述桉叶提取物在制备减肥降脂产品中的应用,所述减肥降脂产品优选为保健品或药物;所述产品优选的以本发明桉叶提取物为唯一活性成分;所述产品优选的还包括辅料,本发明对所述辅料的种类没有特殊限定,采用本领域常规的产品辅料即可;本发明所述的产品剂型优选为散剂、片剂、颗粒剂、胶囊剂、溶液剂、乳剂、混悬剂、注射剂、喷雾剂、气雾剂或粉雾剂等。在本发明中,所述产品包括载体,所述载体优选为口服制剂用的粘合剂、润滑剂、崩解剂、助溶剂、稀释剂、稳定剂、悬浮剂、色素、矫味剂等;可注射制剂用的防腐剂、加溶剂、稳定剂等;局部制剂用的基质、稀释剂、润滑剂、防腐剂等。The present invention also provides the application of the above eucalyptus leaf extract in the preparation of weight-loss and lipid-lowering products, and the weight-loss and lipid-lowering products are preferably health care products or medicines; the product preferably uses the eucalyptus leaf extract of the present invention as the only active ingredient; Said product preferably also includes adjuvant, the present invention has no special limitation to the kind of said adjuvant, just adopt the conventional product adjuvant in this field; The dosage form of the product described in the present invention is preferably powder, tablet, granule, capsule , solution, emulsion, suspension, injection, spray, aerosol or powder mist, etc. In the present invention, the product includes a carrier, and the carrier is preferably a binder, a lubricant, a disintegrant, a solubilizer, a diluent, a stabilizer, a suspending agent, a pigment, a flavoring agent, etc. for oral preparations; Preservatives, solubilizers, stabilizers, etc. for injectable preparations; bases, diluents, lubricants, preservatives, etc. for topical preparations.
下面结合实施例对本发明提供的技术方案进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The technical solutions provided by the present invention will be described in detail below in conjunction with the examples, but they should not be interpreted as limiting the protection scope of the present invention.
实施例1Example 1
将“广林9号”桉树叶原料阴凉干燥后经机械粉碎,粉碎至30目,称取桉叶粉末20kg,装入连续相变萃取釜中密封萃取,萃取压力为1.0MPa,萃取温度为65℃,解析温度为75℃,依次以丁烷、70%乙醇、水作为萃取剂,每次萃取时间为100min,得到桉叶提取液。将桉树叶提取液在60℃、400Pa真空度的条件下进行真空减压浓缩,然后在进风温度200℃、进料速度100rpm、雾化器频率45Hz的条件下进行喷雾干燥,得到桉叶粗提物。桉树叶粗提物过100目硅胶柱,洗脱的流速为40ml/min,用乙醇和乙酸乙酯进行梯度洗脱,乙醇和乙酸乙酯的体积配比依次为0:100、10:90、20:80、30:70、40:60、50:50、60:40、70:30、80:20、90:10、100:0,每个比例洗脱3个柱体积,在70℃、500Pa的条件下真空浓缩乙醇和乙酸乙酯体积比为60:40、70:30、80:20的洗脱液,进风温度250℃、进料速度100rpm、雾化器频率50Hz的条件下进行喷雾干燥,即得桉叶精提物。The eucalyptus leaf raw material of "Guanglin No. 9" was cooled and dried, and then mechanically crushed to 30 meshes. Weighed 20kg of eucalyptus leaf powder and put it into a continuous phase change extraction kettle for sealed extraction. The extraction pressure was 1.0 MPa and the extraction temperature was 65 °C, the analysis temperature is 75 °C, sequentially use butane, 70% ethanol, and water as the extractant, and the extraction time is 100 min each time to obtain the eucalyptus leaf extract. The eucalyptus leaf extract was concentrated under reduced pressure at 60°C and a vacuum of 400Pa, and then spray-dried under the conditions of an inlet air temperature of 200°C, a feed rate of 100rpm, and an atomizer frequency of 45Hz to obtain crude eucalyptus leaves. Extract. The crude extract of eucalyptus leaves was passed through a 100-mesh silica gel column, and the elution flow rate was 40ml/min. Gradient elution was carried out with ethanol and ethyl acetate. The volume ratio of ethanol and ethyl acetate was 0:100, 10:90, 20:80, 30:70, 40:60, 50:50, 60:40, 70:30, 80:20, 90:10, 100:0, each ratio eluted with 3 column volumes, at 70℃, Under the condition of 500Pa, vacuum concentrate the eluent with volume ratio of ethanol and ethyl acetate of 60:40, 70:30, 80:20, the inlet air temperature is 250℃, the feeding speed is 100rpm, and the nebulizer frequency is 50Hz. Spray-dry to obtain the eucalyptus extract.
实施例2Example 2
将“广林9号”桉树叶原料阴凉干燥后经机械粉碎,粉碎至40目,称取桉叶粉末15kg,装入连续相变萃取釜中密封萃取,萃取压力为1.2MPa,萃取温度为60℃,解析温度为70℃,依次以丁烷、65%乙醇、水作为萃取剂,每次萃取时间为120min,收集桉叶提取液。将桉树叶提取液在65℃、500Pa真空度的条件下进行真空减压浓缩,然后在进风温度250℃、进料速度150rpm、雾化器频率50Hz的条件下进行喷雾干燥。桉树叶粗提物过200目硅胶柱,洗脱的流速为35ml/min,用乙醇和乙酸乙酯进行梯度洗脱,乙醇和乙酸乙酯的体积配比依次为0:100、10:90、20:80、30:70、40:60、50:50、60:40、70:30、80:20、90:10、100:0,每个比例洗脱3个柱体积,在70℃、500Pa的条件下真空浓缩乙醇和乙酸乙酯体积比为60:40、70:30、80:20的洗脱液,进风温度300℃、进料速度150rpm、雾化器频率60Hz的条件下进行喷雾干燥,即得桉叶精提物。The "Guanglin No. 9" eucalyptus leaf raw material was cooled and dried, and then mechanically crushed to 40 mesh. Weighed 15kg of eucalyptus leaf powder and put it into a continuous phase change extraction kettle for sealed extraction. The extraction pressure was 1.2MPa and the extraction temperature was 60°C. °C, the analysis temperature is 70 °C, sequentially use butane, 65% ethanol, and water as the extractant, each extraction time is 120min, and collect the eucalyptus leaf extract. The eucalyptus leaf extract was concentrated under reduced pressure at 65° C. and a vacuum of 500 Pa, and then spray-dried at an inlet air temperature of 250° C., a feed rate of 150 rpm, and an atomizer frequency of 50 Hz. The crude extract of eucalyptus leaves was passed through a 200-mesh silica gel column, and the elution flow rate was 35ml/min. Gradient elution was carried out with ethanol and ethyl acetate. The volume ratio of ethanol and ethyl acetate was 0:100, 10:90, 20:80, 30:70, 40:60, 50:50, 60:40, 70:30, 80:20, 90:10, 100:0, each ratio eluted with 3 column volumes, at 70℃, Under the condition of 500Pa, vacuum concentrate the eluent with volume ratio of ethanol and ethyl acetate of 60:40, 70:30, 80:20, the inlet air temperature is 300℃, the feeding speed is 150rpm, and the nebulizer frequency is 60Hz. Spray-dry to get the eucalyptus extract.
实施例3Example 3
将“广林9号”桉树叶原料阴凉干燥后经机械粉碎,粉碎至60目,称取桉叶粉末15kg,装入连续相变萃取釜中密封萃取,萃取压力为1.2MPa,萃取温度为65℃,解析温度为75℃,分别以丁烷、80%乙醇、水作为萃取剂,每次萃取时间为120min,收集桉叶提取液。将桉树叶提取液在60℃、400Pa真空度的条件下进行真空减压浓缩,然后在进风温度200℃、进料速度100rpm、雾化器频率45Hz的条件下进行喷雾干燥,得到桉叶粗提物。桉树叶粗提物过200目硅胶柱,洗脱的流速为35ml/min,用乙醇和石油醚进行梯度洗脱,乙醇和石油醚的体积配比依次为0:100、10:90、20:80、30:70、40:60、50:50、60:40、70:30、80:20、90:10、100:0,每个比例洗脱3个柱体积,在70℃、500Pa的条件下真空浓缩乙醇和乙酸乙酯体积比为60:40、70:30、80:20的洗脱液,进风温度250℃、进料速度100rpm、雾化器频率50Hz的条件下进行喷雾干燥,即得桉叶精提物。The eucalyptus leaf raw material of "Guanglin No. 9" was cooled and dried, and then mechanically crushed to 60 mesh. Weighed 15kg of eucalyptus leaf powder and put it into a continuous phase change extraction kettle for sealed extraction. The extraction pressure was 1.2MPa and the extraction temperature was 65 °C, the analysis temperature was 75 °C, butane, 80% ethanol, and water were used as extraction agents respectively, and the extraction time was 120 min each time to collect the eucalyptus leaf extract. The eucalyptus leaf extract was concentrated under reduced pressure at 60°C and a vacuum of 400Pa, and then spray-dried under the conditions of an inlet air temperature of 200°C, a feed rate of 100rpm, and an atomizer frequency of 45Hz to obtain crude eucalyptus leaves. Extract. The crude extract of eucalyptus leaves was passed through a 200-mesh silica gel column, and the elution flow rate was 35ml/min. Gradient elution was carried out with ethanol and petroleum ether. The volume ratio of ethanol and petroleum ether was 0:100, 10:90, 20: 80, 30:70, 40:60, 50:50, 60:40, 70:30, 80:20, 90:10, 100:0, each ratio eluted with 3 column volumes, at 70℃, 500Pa Under the conditions of vacuum concentration ethanol and ethyl acetate volume ratio of 60:40, 70:30, 80:20 eluate, spray drying under the conditions of air inlet temperature 250 ℃, feed speed 100rpm, atomizer frequency 50Hz , that is, eucalyptus extract.
实验例1液相色谱分析Experimental Example 1 Liquid Chromatography Analysis
对实施例1制得的桉叶精提物进行液相色谱分析,液相条件为:Diamonsil C18色谱柱(250×4.6mm,5μm);检测波长270nm;流动相为10%-90%甲醇梯度洗脱1h,流速为1mL/mim;进样量20μL。The eucalyptus extract obtained in Example 1 is subjected to liquid chromatography analysis, and the liquid phase conditions are: Diamonsil C18 chromatographic column (250 × 4.6mm, 5 μm); detection wavelength 270nm; mobile phase is a gradient of 10%-90% methanol Elution was performed for 1 hour, and the flow rate was 1 mL/mim; the injection volume was 20 μL.
结果如图1所示,其中:1、Gemin D;2、月见草素B;3、5-甲氧基糖醛;4、英国栎鞣花素;5、特里马素Ⅰ;6、绿原酸;7、特里马素Ⅱ;8、1,2,3,6-四没食子酰葡萄糖;9、没食子酸乙酯;10、1,2,3,4,6-五没食子酰葡萄糖;11、槲皮素-3-O-葡萄糖醛酸苷。The results are shown in Figure 1, in which: 1. Gemin D; 2. Evening primrose B; 3. 5-methoxyfurfural; 4. Quercus ellagitannin; 5. Trimazin Ⅰ; 6. Chlorogenic acid; 7. Terimazol Ⅱ; 8. 1,2,3,6-tetragalloyl glucose; 9. Ethyl gallate; 10. 1,2,3,4,6-pentagalloyl glucose ; 11. Quercetin-3-O-glucuronide.
实验例2提取率、总酚含量测定Experimental example 2 extraction rate, total phenol content determination
对实施例1和实施例2中的桉叶精提物质量进行测定,计算提取率(提取率=桉叶精提物质量/桉叶粉末质量×100%);The eucalyptus leaf extract quality in embodiment 1 and
采用福林酚法检测总酚含量,结果如下表1所示:The total phenol content was detected by the Folin phenol method, and the results are shown in Table 1 below:
表1桉叶提取物的提取结果Table 1 Extraction Results of Eucalyptus Leaf Extract
实验例3减肥降脂作用研究Experimental Example 3 Research on Weight Loss and Fat-lowering Effects
试验动物:雄性,SPF级C57BL/6J小鼠,体重约(23±2g),购于北京维通利华实验动物技术有限公司;Experimental animals: male, SPF grade C57BL/6J mice, weighing about (23 ± 2g), purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.;
试验药物和试剂:桉叶提取物,总酚含量约55%;生理盐水;等试剂盒;总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)等试剂盒;Test drugs and reagents: eucalyptus leaf extract, total phenol content about 55%; normal saline; etc. kits; total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL-C), high-density lipoprotein Protein (HDL-C) and other kits;
饲料:60%高脂模型饲料、10%低脂对照饲料购于南通特洛菲饲料科技有限公司;Feed: 60% high-fat model feed and 10% low-fat control feed were purchased from Nantong Trophy Feed Technology Co., Ltd.;
实验方法:适应7d后,将32只C57BL/6J小鼠分为四组,分别为正常对照组,模型对照组、桉叶提取物低剂量组(50mg/kg)和桉叶提取物高剂量组(100mg/kg)。正常对照组喂养10%低脂对照饲料,而模型组和低、高剂量桉叶提取物组喂养60%高脂模型饲料,喂养周期为10周。第1d开始,对正常对照组和模型对照组小鼠灌胃生理盐水,对低、高剂量桉叶提取物组小鼠分别灌胃50mg/kg、100mg/kg桉叶提取物。喂养周期结束后,处死小鼠,并收集血清、脏器、脂肪-80℃保存待测。Experimental method: After 7 days of adaptation, 32 C57BL/6J mice were divided into four groups, which were normal control group, model control group, low-dose eucalyptus extract group (50mg/kg) and high-dose eucalyptus extract group (100mg/kg). The normal control group was fed with 10% low-fat control feed, while the model group and low-dose and high-dose eucalyptus extract groups were fed with 60% high-fat model feed, and the feeding period was 10 weeks. From the 1st day, the mice in the normal control group and the model control group were given intragastric administration of normal saline, and the mice in the low-dose and high-dose eucalyptus extract groups were given intragastric administration of 50 mg/kg and 100 mg/kg eucalyptus extract. After the feeding period, the mice were sacrificed, and the serum, organs, and fat were collected and stored at -80°C for testing.
实验对小鼠体重、摄食量、脏器系数、脂肪系数、血清脂质水平等进行了测定,结果如下。所有实验数据均使用SPSS 17.0统计软件分析。多组间比较采用单因素方差分析(One-wayAnova),两两比较采用Duncan法。结果以均数±标准差表示,p<0.05为差异有显著性意义。The body weight, food intake, organ coefficient, fat coefficient, serum lipid level, etc. of the mice were measured in the experiment, and the results are as follows. All experimental data were analyzed using SPSS 17.0 statistical software. One-way ANOVA was used for comparison among multiple groups, and Duncan's method was used for pairwise comparison. The results were expressed as mean ± standard deviation, and p<0.05 was considered a significant difference.
试验期间,每周对各组小鼠体重进行称量并记录,各组小鼠体重及体重增长量如表2所示。During the experiment, the body weight of the mice in each group was weighed and recorded every week, and the body weight and weight gain of the mice in each group are shown in Table 2.
表2小鼠体重增长量(g)Table 2 Mouse body weight gain (g)
注:表中数据为样品平均值±标准差;与正常对照组相比,**p<0.01,与模型对照组相比##p<0.05。Note: The data in the table are the sample mean ± standard deviation; compared with the normal control group, **p<0.01, compared with the model control group ##p<0.05.
由表2可知,模型对照组小鼠体重增长率显著高于正常对照组,表明小鼠肥胖模型建立成功。与模型对照组相比,桉叶提取物低、高剂量组小鼠体重增长量均有所降低,其中,高剂量组降低体重效果极显著。结果表明,摄入一定剂量桉叶提取物能够有效抑制由高脂饮食引起的机体肥胖,具有良好的减肥效果。It can be seen from Table 2 that the weight growth rate of the mice in the model control group was significantly higher than that in the normal control group, indicating that the mouse obesity model was successfully established. Compared with the model control group, the weight gain of the mice in the low-dose and high-dose groups of eucalyptus leaf extract was reduced, and the weight loss effect of the high-dose group was extremely significant. The results show that taking a certain dose of eucalyptus extract can effectively inhibit the body obesity caused by high-fat diet, and has a good weight loss effect.
试验对各组小鼠附睾脂肪、腹股沟脂肪、肾周脂肪、棕色脂肪及肝脏进行称重,并计算其指数,结果如表3所示。In the experiment, the epididymal fat, inguinal fat, perirenal fat, brown fat and liver of mice in each group were weighed, and their indexes were calculated. The results are shown in Table 3.
表3小鼠肝脏系数和脂肪系数(%)Table 3 mouse liver coefficient and fat coefficient (%)
注:表中数据为样品平均值±标准差;与正常对照组相比,**p<0.01,与模型对照组相比##p<0.05。Note: The data in the table are the sample mean ± standard deviation; compared with the normal control group, **p<0.01, compared with the model control group ##p<0.05.
由表3可知,桉叶提取物低、高剂量组小鼠肝脏系数显著低于模型对照组,表明桉叶提取物能够缓解肥胖导致的肝脏充血肿胀、肥大增生,减轻脂肪肝程度。此外,与模型对照组相比,桉叶提取物低、高剂量组小鼠腹股沟脂肪、附睾脂肪及肾周脂肪这三种白色脂肪系数均显著降低,反映了桉叶提取物能够有效减少机体体内脂肪的堆积,起到减肥效果。It can be seen from Table 3 that the liver coefficient of mice in low and high dose groups of eucalyptus leaf extract was significantly lower than that of the model control group, indicating that eucalyptus leaf extract can relieve liver congestion, swelling, hypertrophy and hyperplasia caused by obesity, and reduce the degree of fatty liver. In addition, compared with the model control group, the three white fat coefficients of the mice in the eucalyptus extract low- and high-dose groups, including inguinal fat, epididymis fat, and perirenal fat, were significantly reduced, reflecting that eucalyptus extract can effectively reduce the amount of fat in the body. The accumulation of fat plays a role in weight loss.
检测小鼠血清中总甘油三酯、总胆固醇、低密度脂蛋白和高密度脂蛋白的含量,结果如下图2~5所示。The contents of total triglyceride, total cholesterol, low-density lipoprotein and high-density lipoprotein in mouse serum were detected, and the results are shown in Figures 2-5 below.
由图2~5可知,相较于高脂饮食对照组,桉叶提取物低、高剂量组小鼠血清中总甘油三酯、总胆固醇、低密度脂蛋白显著降低,且血清中HDL-C水平显著上升(P<0.01),表明本发明中的桉叶提取物能够有效改善高脂饮食诱导的机体脂质代谢紊乱,具有良好的降脂功效。It can be seen from Figures 2 to 5 that compared with the high-fat diet control group, the total triglyceride, total cholesterol, and low-density lipoprotein in the serum of the mice in the low- and high-dose eucalyptus extract groups were significantly reduced, and the serum HDL-C The level increased significantly (P<0.01), indicating that the eucalyptus leaf extract in the present invention can effectively improve the body lipid metabolism disorder induced by a high-fat diet, and has a good lipid-lowering effect.
由以上实施例可知,本发明提供的桉叶提取方法提取率高,所得的桉叶提取物总酚含量高,活性物质种类多。且通过本发明制备方法得到的桉叶提取物能够有效抑制由高脂饮食引起的机体肥胖,具有良好的减肥效果,能够缓解肥胖导致的肝脏充血肿胀、肥大增生,减轻脂肪肝程度,能够有效减少机体体内脂肪的堆积,起到减肥效果,还可以有效改善高脂饮食诱导的机体脂质代谢紊乱,具有良好的降脂功效。It can be seen from the above examples that the eucalyptus leaf extraction method provided by the present invention has a high extraction rate, and the obtained eucalyptus leaf extract has a high total phenol content and a wide variety of active substances. And the eucalyptus leaf extract obtained by the preparation method of the present invention can effectively inhibit body obesity caused by high-fat diet, has a good weight loss effect, can relieve liver congestion and swelling caused by obesity, hypertrophy and hyperplasia, alleviate the degree of fatty liver, and can effectively reduce The accumulation of fat in the body has the effect of losing weight, and can also effectively improve the lipid metabolism disorder of the body induced by a high-fat diet, and has a good lipid-lowering effect.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that, for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications can also be made. It should be regarded as the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211003304.4A CN115400165B (en) | 2022-08-15 | 2022-08-15 | Eucalyptus extract, preparation method and application thereof in preparation of weight-losing and lipid-lowering products |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211003304.4A CN115400165B (en) | 2022-08-15 | 2022-08-15 | Eucalyptus extract, preparation method and application thereof in preparation of weight-losing and lipid-lowering products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115400165A true CN115400165A (en) | 2022-11-29 |
| CN115400165B CN115400165B (en) | 2023-11-24 |
Family
ID=84160885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211003304.4A Active CN115400165B (en) | 2022-08-15 | 2022-08-15 | Eucalyptus extract, preparation method and application thereof in preparation of weight-losing and lipid-lowering products |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115400165B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06133732A (en) * | 1992-10-28 | 1994-05-17 | Okinawa Yuukari Farm:Kk | Production of eucalyptus powder and eucalyptus extract |
| CN1406623A (en) * | 2001-09-11 | 2003-04-02 | 长冈香料株式会社 | Levulose absorption retardant, compound, food and levulose absorption repressor |
| JP2008163004A (en) * | 2006-12-08 | 2008-07-17 | Bhn Kk | Fat accumulation inhibitor |
| CN108740332A (en) * | 2018-05-29 | 2018-11-06 | 华南农业大学 | A kind of folium eucalypti polyphenol feed addictive and preparation method thereof improving meat quality |
-
2022
- 2022-08-15 CN CN202211003304.4A patent/CN115400165B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06133732A (en) * | 1992-10-28 | 1994-05-17 | Okinawa Yuukari Farm:Kk | Production of eucalyptus powder and eucalyptus extract |
| CN1406623A (en) * | 2001-09-11 | 2003-04-02 | 长冈香料株式会社 | Levulose absorption retardant, compound, food and levulose absorption repressor |
| JP2008163004A (en) * | 2006-12-08 | 2008-07-17 | Bhn Kk | Fat accumulation inhibitor |
| CN108740332A (en) * | 2018-05-29 | 2018-11-06 | 华南农业大学 | A kind of folium eucalypti polyphenol feed addictive and preparation method thereof improving meat quality |
Non-Patent Citations (3)
| Title |
|---|
| KEIICHIRO SUGIMOTO1: "Anti-obesity effect of eucalyptus leaf extract containing oenothein B in healthy Japanese adults: a randomized, placebo-controlled, double-blind, parallel-group study", vol. 12, no. 5, pages 242 - 263 * |
| 李萃邦: "桉树叶活性成分提取方法及生物活性研究进展", 湖北农业科学, vol. 57, no. 06, pages 12 - 16 * |
| 肖苏尧;陈雪香;陈运娇;王俊亮;汤杰;曹庸;: "桉叶抗氧化作用研究进展", vol. 33, no. 14, pages 396 - 399 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115400165B (en) | 2023-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bopana et al. | Asparagus racemosus—Ethnopharmacological evaluation and conservation needs | |
| US8445035B2 (en) | Dietary supplements containing extracts of aronia and method of using same to promote weight loss | |
| EP2436388B1 (en) | Composition for increasing the bioavailability of saponin | |
| US20010006983A1 (en) | Multicomponent biological vehicle | |
| CN101454015A (en) | Extracts and methods comprising green tea species | |
| US9855306B2 (en) | Portulaca oleracea L. extract feed additive and preparation method thereof | |
| CN1166387C (en) | Extraction method of effective components in Maca | |
| CN108815218B (en) | Pharmaceutical composition and use thereof | |
| CN103417601B (en) | A kind of medical composition and its use with regulating blood lipid action | |
| CN110279033A (en) | A kind of lupulus extract feed addictive and preparation method thereof | |
| CN100534508C (en) | Method for extracting effective sites group of smilax China root | |
| AU2019100737A4 (en) | Anti-Helicobacter Pylori Traditional Chinese Medicine composition and applications | |
| KR101402852B1 (en) | Fermented bellflower pills and Preparation thereof | |
| CN102283913A (en) | Radix aconiti carmichaeli extract and application thereof | |
| CN115400165A (en) | Eucalyptus leaf extract, preparation method and application thereof in preparation of weight-losing and lipid-lowering products | |
| CN108813465A (en) | A kind of fig function chewable tablets and preparation method thereof | |
| CN112675278A (en) | Composition for moistening lung to arrest cough and inhibiting lung inflammatory reaction and preparation method and application thereof | |
| CN106723010A (en) | The method of Extraction and enrichment polyphenol from quinoa seed | |
| CN102813713B (en) | Rhizoma dryopteris crassirhizomae and fructus crataegi composition, preparation method and application of composition | |
| CN101125154A (en) | Taishan Radix Radix Granules and Preparation Method | |
| CN116983375A (en) | Traditional Chinese medicine powder for treating newcastle disease and preparation method thereof | |
| JP7035294B2 (en) | Herbal composition for the prevention or treatment of benign prostatic hyperplasia disease | |
| CN108379495B (en) | Use of galangal extract in the preparation of preparations for preventing and/or treating non-alcoholic fatty liver disease | |
| CN100421689C (en) | Preparation process and application of total phenolic acid part of hawthorn | |
| CN110755464A (en) | Health product containing stevia extract and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |